Enliven Therapeutics, Inc (ELVN) Tops Q2 EPS by 6c

Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q2 EPS of ($0.49), $0.06 better than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.

You May Also Be Interested In

• Putin Said To Plan Ukraine Escalation, Seeing Talks Fruitless - Bloomberg
• Apple foldable iPhone to ship over 10 million units in first year, IDC estimates
• Cycurion announces 1-for-8 reverse stock split, cites margin gains